Pharma
Why von der Leyen’s Big Tech tax plan is bluster
There are major hurdles to overcome for the EU to retaliate against U.S. digital companies.
Trump says pharma tariffs will entice back drug production. They won’t.
WHO pandemic agreement within striking distance
EU readies counterstrike on Big Tech and US banks over Trump’s mega tariffs
Germany must leave its comfort zone
EU regulator rejects Lilly’s Alzheimer’s drug
Europe looks to poach US researchers as Trump cuts funding
Trump doesn’t want ‘to hurt Ireland’ — but he might
Ireland’s visiting prime minister endures an excruciating 45 minutes in Trump’s live-TV star chamber as the U.S. leader swings at Brussels, not Dublin.
Belgium wanted a drug shortages bill. It’s not happy with the EU’s plan.
Belgium first called for a law to tackle drug shortages in May 2023.
EU plans to boost medicines manufacturing in drug shortages bill
The Critical Medicines Act is the EU’s attempt to tackle manufacturing dependencies on India and China.
Ireland’s leader seeks to survive a brush with Trump
White House events for St. Patrick’s Day are normally a diplomatic dream for Dublin. This year is completely different — and dangerous for Ireland’s America-fueled economy.
Pharma braces for tariffs as Trump threatens to buck trade convention
Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues.
Denmark wanted advice on handling Trump. It turned to Ozempic’s boss.
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug is. And its success has thrust him — reluctantly — into the limelight.
RFK Jr. now runs America’s health agencies
The United States Senate confirmed Robert F. Kennedy Jr. in a 52-48 vote Thursday to lead the Department of Health and Human Services. He will be sworn in later today.
Where are the pain points of a transatlantic trade war?
Trump calls the EU an “atrocity” for running a huge trade surplus with the U.S., but that largely overlooks America’s massive services sector.
Europe faces growing threat of fake drugs, Europol warns
There has been a rise in sub-standard, falsely labelled or falsified medicines.
PFAS: Working toward a sustainable future while protecting patient care
Pharma and medtech companies are invited to join a project on PFAS exposure, emissions and end-of-life management in the health care sector
Biotechs ‘cry for help’ to fix antibiotics market failure
Developers are reluctantly shelving promising drugs due to market failure.
Patient-centered innovation: Can Europe lead the way?
We can’t make true progress on unmet medical needs unless we understand what the patients themselves think they need or say is missing from their treatment options.
Doctors present first barrier for rare disease patients
Overcoming the doctor’s ego is a first hurdle for many rare disease patients in search of a diagnosis.
Regulatory innovation can unlock pharma competitiveness
By embracing the agility and efficiency adopted during the pandemic, the EU can become a life sciences leader again
Ireland wants a new government in time for Trump
As Irish election winners tussle for positions of power, Donald Trump’s Jan. 20 inauguration adds a sense of urgency in Dublin.
Poland takes on wealthier countries over access to new medicines
The country sees securing equal access to innovative medicines as its presidency goal in pharma legislative talks.
How to navigate Poland’s EU presidency policy agenda like a pro
The country’s half year at the Council’s helm coincides with a changing of the guard at the European Commission.
Von der Leyen’s first Commission: The final verdict
Who’s at the top of the class and who flunked? Here are POLITICO’s grades for each 2019-2024 European commissioner.
Von der Leyen’s Commission dodges public responsibility over Pfizergate texts
European Commission lawyer “cannot deny” texts were exchanged, but argued they were not “substantive.”
Von der Leyen’s private texting habits face court scrutiny
Messages about the secretive Covid vaccine deal between the European Commission president and the Pfizer boss must be revealed, the New York Times will argue.
Amid existential crisis, US Democrats clash over who to blame – and what to do next
Everyone agrees they lost the working class, but they’re deeply divided on where to place the blame — and what to do about it.
Hungary’s Várhelyi to face 2nd round of written questions
MEPs hold back the green light for the controversial Hungarian Commission nominee.
5 things to know about Olivér Várhelyi’s health commissioner hearing
Hungarian candidate didn’t snap under pressure despite repeated grilling on abortion rights.
Trump’s in. Here’s what it means for Europe.
From energy and trade to finance and defense, here’s how Donald Trump’s second presidency will impact EU policy.